산소요법 장비 - 세계 시장 인사이트, 경쟁 상황 및 시장 예측(2030년)

Oxygen Therapy Equipment Market By Product Type (Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, Others], Disposables And Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, Others]), By Portability (Stationary, Portable), By Application (COPD, Asthma, Respiratory Distress Syndrome, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Center, Home Care Settings, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to outbreak of covid-19 pandemic and increasing prevalence of respiratory diseases

Global Oxygen Therapy Equipment Market was valued at USD 2.69 billion in 2023, growing at a CAGR of 8.29% during the forecast period from 2024 to 2030 to reach USD 4.33 billion by 2030. The Oxygen Therapy Equipment Market is witnessing positive growth owing to the rising incidence of respiratory ailments like COPD, sleep apnea, asthma, and others, the outbreak of the COVID-19 pandemic, significant usage of these devices in critical care, mounting adoption of minimally invasive procedures, rapid technical innovation in product development, all factors contributing to the growth of the Oxygen Therapy Equipment market during the forecast period from 2024-2030.

Oxygen Therapy Equipment Market Dynamics:

Oxygen Therapy Equipment Market has significantly increased due to the growing burden of respiratory diseases throughout the world, and Oxygen Therapy Equipment plays an important role in providing supplemental oxygen for pulmonary disorders such as COPD, and asthma.

As per World Health Organization (WHO) 2019, asthma affected an estimated 262 million people and caused 461,000 deaths 2019 worldwide. Additionally, chronic obstructive pulmonary disease (COPD) is the third-most-leading cause of death, causing 3.23 million deaths worldwide. Environmental exposure to tobacco smoke, indoor air pollution, and occupational dust, fumes, and chemicals are important risk factors for COPD. As per WHO 2022 data, Pneumonia alone accounts for 800, 000 deaths per year. It is estimated that 20-40% of these deaths could be prevented with the availability of oxygen therapy devices, such as Oxygen concentrators are used by patients requiring supplemental oxygen for respiratory disorders, thus, emphasizing the demand for Global Oxygen Therapy Equipment.

In addition, the oxygen concentrators field is advancing at a great pace, stimulated by advancements in innovative technologies. For instance, novel devices have been developed that automatically adjust oxygen flow rates to the needs of every patient, in order to maintain stable oxygen-saturation levels. Also, manufacturers are working towards a silent compressor motor, allowing for minimal noise pollution in confined spaces. These systems can potentially reduce medical error, improve morbidity and mortality, and reduce care costs. Such technological advancement in the field of Oxygen Therapy Equipment is likely to boost the Global Oxygen Therapy Equipment Market.

Another factor responsible for the growth of the Oxygen Therapy Equipment Market is the outbreak of the COVID-19 pandemic. The demand for Oxygen Therapy Equipment is increasing at present, as the continuous rise in the COVID-19 cases across the globe is expected to increase the demand for Oxygen Therapy Equipment to manifolds. For instance, as per the World Health Organization (WHO), as of 14 April 2022, there have been 500,186,525 confirmed cases of COVID-19.

Moreover, increasing awareness among the population regarding applications of Oxygen Therapy Equipment is also likely to fuel the Global Oxygen Therapy Equipment market.

Certain factors such as the strict regulatory guidelines by the government causing delays in product approvals, and the high cost of oxygen therapy pose a minor hurdle for the growth of the Oxygen Therapy Equipment market.

Oxygen Therapy Equipment Market Segment Analysis:

Oxygen Therapy Equipment Market By Product Type (Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, Others], Disposables and Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, Others]), By Portability (Stationary, Portable), By Application (COPD, Asthma, Respiratory Distress Syndrome, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Center, Home Care Settings, Others), and Oxygen Therapy Equipment Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Oxygen Therapy Equipment Market by Product Type segment, in the Systems subsegment, the HFNO (High-Flow Nasal Cannula Oxygenation) Devices are the fastest growing in the Global Oxygen Therapy Equipment market during the forecast period from 2024-2030.

The rapid growth of this product segment can be attributed to their widespread use in hospitals owing to their convenience, faster, and continuous care to patients.

High-flow nasal cannula oxygenation has distinct advantages over other oxygen devices because of its unique effects on respiratory physiology. In particular, adjustable oxygen delivery and flow-dependent carbon dioxide clearance reduce the work of breathing and better match inspiratory demand during respiratory distress.

Moreover, High-flow nasal cannula oxygenation has been shown to have superior clinical efficacy compared with conventional low-flow oxygen supplementation and noninvasive positive pressure ventilation in acute hypoxemic respiratory failure. High-flow nasal cannula oxygenation also prevents reintubations in medical and postoperative surgical populations, provides preoxygenation for laryngoscopy, and supports oxygenation during bronchoscopy.

Moreover, new/existing hospitals and healthcare centers in rural regions of developing countries such as India, China, and Brazil, are equipped with advanced facilities for patient comfort, which is expected to enhance the market potential.

Hence, all the above-mentioned factors are expected to drive the segment growth of the Oxygen Therapy Equipment market as the demand is rising.

North America is expected to dominate the overall Oxygen Therapy Equipment Market:

North America is expected to dominate the overall Oxygen Therapy Equipment market during the forecast period. This domination is due to the rising prevalence of respiratory diseases such as COPD, asthma, and rising cases of carbon monoxide poisoning, among others.

For instance, as per the Centers for Disease Control and Prevention 2022 data, the age-adjusted prevalence of COPD among adults in the US during 2019 varied considerably by state, from <4.5% in California, Colorado, Hawaii, Massachusetts, Minnesota, and Utah to >9% in Alabama, Arkansas, Kentucky, and West Virginia.

As per National Health Interview Survey data 2019, approximately 25 million Americans have asthma. This equals to about 1 in 13 Americans, including 8% of adults and 7% of children. Moreover, about 20 million US adults age 18 and over have asthma.

Additionally, according to National Center for Health Statistics, in 2019, 3,524 people died from asthma. Many of these deaths are avoidable with proper treatment and care. Thus, the burgeoning cases of respiratory diseases will contribute to the growth of the Oxygen Therapy Equipment Market in the region as the demand for Oxygen Therapy Equipment will increase.

Moreover, burgeoning cases of Covid-19 in the country are also expected to surge the demand for Oxygen Therapy Equipment in the upcoming years. For instance, as per the WHO latest report, 14 April 2022, there have been 500,186,525 confirmed cases of COVID-19 in the country.

Further, the US represents the largest market worldwide supported by developed healthcare infrastructure and rising adoption of advanced non-invasive patient monitoring technologies. In addition presence of key market players such as Koninklijke Philips N.V., Invacare Corporation, and Inogen, Inc., among others is also expected to boost the market.

Therefore, the interplay of various factors such as the presence of a large patient population, as well as new product launches in the region is expected to boost the North America Oxygen Therapy Equipment market during the forecast period.

Oxygen Therapy Equipment Market Key Players:

Some of the key market players operating in the Oxygen Therapy Equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Dragerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited among others.

Recent Developmental Activities in the Oxygen Therapy Equipment Market:

• On June 18, 2020, Vincent Medical Holdings Limited a global respiratory medical device supplier announced that the Group has entered into a supply agreement with TAMER Healthcare regarding the supply of InspiredTM O2FLO High Flow Respiratory Humidifier ("O2FLO") and the dedicated disposables to the Kingdom of Saudi Arabia.
• On April 03, 2019, Inogen, Inc. announced its launch of Inogen One G5, a lightweight and easy-to-carry oxygen concentrator.

Key Takeaways from the Oxygen Therapy Equipment Market Report Study

• Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Oxygen Therapy Equipment market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for the last 3 years
• Key companies dominating the Global Oxygen Therapy Equipment Market.
• Various opportunities are available for the other competitor in the Oxygen Therapy Equipment Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Oxygen Therapy Equipment market growth in the coming future?

Target Audience who can be benefited from this Oxygen Therapy Equipment Market Key Report Study

• Oxygen Therapy Equipment providers
• Research organizations and consulting companies
• Oxygen Therapy Equipment related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders in Oxygen Therapy Equipment
• Various End-users want to know more about the Oxygen Therapy Equipment Market and the latest technological developments in the Oxygen Therapy Equipment market.

Frequently Asked Questions for Oxygen Therapy Equipment Market:

1. What is Oxygen Therapy Equipment?

Oxygen Therapy Equipment is a device used for providing a safe source of oxygen-enriched air. These devices draw room air through a series of filters that remove dust, bacteria, and other particulates.

2. What is the market for Global Oxygen Therapy Equipment?

Global Oxygen Therapy Equipment Market was valued at USD 2.69 billion in 2023, growing at a CAGR of 8.29% during the forecast period from 2024 to 2030 to reach USD 4.33 billion by 2030.

3. What are the drivers for Global Oxygen Therapy Equipment?

The major drivers for Oxygen Therapy Equipment are the rising incidence of respiratory ailments like COPD, sleep apnea, asthma, and others, the outbreak of the COVID-19 pandemic, growing cases of Carbon Monoxide poisoning, significant usage of these devices in critical care, mounting adoption of minimally invasive procedures, rapid technical innovation in product development.

4. What are the key players operating in Global Oxygen Therapy Equipment?

Some of the key market players operating in the Oxygen Therapy Equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Dragerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited and others.

5. Which region has the highest share in the Oxygen Therapy Equipment market?

North America is expected to dominate the overall Oxygen Therapy Equipment market during the forecast period, 2024 to 2030. This domination is due to the rising prevalence of respiratory diseases such as COPD, asthma, and rising cases of carbon monoxide poisoning, among others, the outbreak of the COVID-19 pandemic in the region.

Table of Contents

1.Oxygen Therapy Equipment Market Report Introduction

2.Oxygen Therapy Equipment Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Oxygen Therapy Equipment Market Key factors analysis

• 4.1. Oxygen Therapy Equipment Market Drivers
  • 4.1.1. Rising Incidence of Respiratory Ailments
  • 4.1.2. The Outbreak of COVID-19 Pandemic
  • 4.1.3. Significant Usage of these Devices in Critical Care
  • 4.1.4. Rapid Technical Innovation in Product Development
• 4.2. Oxygen Therapy Equipment Market Restraints and Challenges
  • 4.2.1. Strict Regulatory Guidelines by the Government Causing Delays in Product Approvals
  • 4.2.2. The High Cost of Therapy
• 4.3. Oxygen Therapy Equipment Market Opportunities
  • 4.3.1. Untapped Potential of Emerging Markets
  • 4.3.2. Increasing Awareness Regarding Oxygen Therapy

5. Oxygen Therapy Equipment Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Oxygen Therapy Equipment Market

7. Oxygen Therapy Equipment Market layout

• 7.1. By Product Type
  • 7.1.1. Systems
    • 7.1.1.1. HFNO (High-Flow Nasal Cannula Oxygenation) Devices
    • 7.1.1.2. Oxygen Concentrators
    • 7.1.1.3. Ventilators
    • 7.1.1.4. Others
  • 7.1.2. Disposables and Accessories
    • 7.1.2.1. Oxygen Masks
    • 7.1.2.2. Nasal Cannulas
    • 7.1.2.3. Resuscitator Bags
    • 7.1.2.4. Others
• 7.2. By Portability
  • 7.2.1. Stationary
  • 7.2.2. Portable
• 7.3. By Application
  • 7.3.1. COPD
  • 7.3.2. Asthma
  • 7.3.3. Respiratory Distress Syndrome
  • 7.3.4. Others
• 7.4. By End User
  • 7.4.1. Hospitals and Clinics
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Home Care Settings
  • 7.4.4. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. North America Oxygen Therapy Equipment Market, by Product Type
    • 7.5.1.2. North America Oxygen Therapy Equipment Market, by Portability
    • 7.5.1.3. North America Oxygen Therapy Equipment Market, by Application
    • 7.5.1.4. North America Oxygen Therapy Equipment Market, by End User
    • 7.5.1.5. North America Oxygen Therapy Equipment Market, by Country
    • 7.5.1.5.1. United States
    • 7.5.1.5.2. Canada
    • 7.5.1.5.3. Mexico
  • 7.5.2. Europe
    • 7.5.2.1. Europe Oxygen Therapy Equipment Market, by Product Type
    • 7.5.2.2. Europe Oxygen Therapy Equipment Market, by Portability
    • 7.5.2.3. Europe Oxygen Therapy Equipment Market, by Application
    • 7.5.2.4. Europe Oxygen Therapy Equipment Market, by End User
    • 7.5.2.5. Europe Oxygen Therapy Equipment Market, by Country
    • 7.5.2.5.1. France
    • 7.5.2.5.2. Germany
    • 7.5.2.5.3. United Kingdom
    • 7.5.2.5.4. Italy
    • 7.5.2.5.5. Spain
    • 7.5.2.5.6. Russia
    • 7.5.2.5.7. Rest of Europe
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. Asia-Pacific Oxygen Therapy Equipment Market, by Product Type
    • 7.5.3.2. Asia-Pacific Oxygen Therapy Equipment Market, by Portability
    • 7.5.3.3. Asia-Pacific Oxygen Therapy Equipment Market, by Application
    • 7.5.3.4. Asia-Pacific Oxygen Therapy Equipment Market, by End User
    • 7.5.3.5. Asia-Pacific Oxygen Therapy Equipment Market, by Country
    • 7.5.3.5.1. China
    • 7.5.3.5.2. Japan
    • 7.5.3.5.3. India
    • 7.5.3.5.4. Australia
    • 7.5.3.5.5. South Korea
    • 7.5.3.5.6. Rest of Asia Pacific
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. RoW Oxygen Therapy Equipment Market, by Product Type
    • 7.5.4.2. RoW Oxygen Therapy Equipment Market, by Portability
    • 7.5.4.3. RoW Oxygen Therapy Equipment Market, by Application
    • 7.5.4.4. RoW Oxygen Therapy Equipment Market, by End User
    • 7.5.4.5. RoW Oxygen Therapy Equipment Market, by Country
    • 7.5.4.5.1. Middle East
    • 7.5.4.5.2. Africa
    • 7.5.4.5.3. South America

8. Oxygen Therapy Equipment Global Company Share Analysis - Key 3-5 Companies

9. Oxygen Therapy Equipment Company and Product Profiles

• 9.1. Koninklijke Philips N.V.
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Invacare Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Inogen, Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Dragerwerk AG & Co. KgaA
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. ICU Medical, Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. CAIRE Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Fisher & Paykel Healthcare Limited
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Armstrong Medical
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Vyaire Medical, Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Hamilton Medical
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Shenzhen Comen Medical Instruments Co., Ltd.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. BMC Medical Co., Ltd.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Allied Medical Limited
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Teleflex Incorporated
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. HERSILL
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Chart Industries, Inc.
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. DeVilbiss Healthcare LLC
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. GCE Group
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Oxygen Solutions Inc.
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Besco Medical Limited
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us